The Phage Display Laboratory is dedicated to advancing next-generation recombinant monoclonal antibody discovery against emerging and re-emerging viral diseases. The laboratory integrates molecular biology, immunology, recombinant DNA technology, and protein engineering approaches to develop high-affinity monoclonal antibodies and antibody fragments against medically important viral pathogens. This lab focuses on the identification of virus-specific binders for applications in diagnostics, therapeutics, and vaccine research